Pharmacokinetics and Safety of Levornidazole Disodium Phosphate for Injection in Chinese Patients With Hepatic Impairment

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Objective: To evaluate the pharmacokinetics and safety of a single intravenous dose of levornidazole disodium phosphate for Injection in subjects with mild hepatic impairment (Child-Pugh A), moderate hepatic impairment (Child-Pugh B), and healthy subjects.
Epistemonikos ID: 323ed8b12fae348dd5f24b5d12833eaf95a4a753
First added on: Oct 31, 2026